New EU-funded project REBECCA to improve post-treatment in breast cancer

European Health Management Association (EHMA) is a partner in a new EU-funded project, REBECCA, which aims to improve post-treatment in breast cancer. REBECCA, stands for REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi-source data, will tap into the potential of Real-World Data to support clinical research and to improve existing clinical workflows.

REBECCA will combine clinical data with data obtained from multiple wearable, online behaviour and registry data to study the complex array of chronic comorbidities developed during breast cancer recovery. The data will be deployed within 7 clinical studies in 3 countries, Norway, Spain and Sweden, involving over 650 individuals, and it will help shape future guidelines and practices for post-cancer treatment. Best practices resulting from the studies will be disseminated to researchers, public health and regulatory bodies throughout Europe.

EHMA is one of the 12 project partners and is a leader of Work Package 8 on Dissemination and communication. EHMA will develop and implement a communication strategy, aiming to reach out to the different target audience segments of REBECCA and raise awareness about the project and its results. EHMA will also build and engage a network of public health stakeholders to promote the value of using Real-World data in research and clinical practice in the breast cancer domain.

REBECCA kicked off in April 2021 and is set to last until March 2025, with a budget of 5.2 million EUR provided under the European Union’s Horizon 2020 research and innovation programme. The project brings together clinical and technological universities, industry leaders, public health experts, and patient associations from 7 European countries to work together to shape guidelines and practices for post-cancer treatment.

» Read the official press release
» Visit the REBECCA project website

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 965231.

Posted in EU projects, News

Leave a Reply

Your email address will not be published. Required fields are marked *